You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,023,391


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,023,391 protect, and when does it expire?

Patent 9,023,391 protects OMEPRAZOLE and is included in one NDA.

This patent has nine patent family members in eight countries.

Summary for Patent: 9,023,391
Title:Stable benzimidazole formulation
Abstract: A stable composition with a benzimidazole derivative, such as Omeprazole, which does not contain a separating layer between the active compound and an enteric coating layer. Instead, the enteric coating layer is applied as a solution with a pH value of at least 6.5, and more preferably in a range of from about 7 to about 10, directly to the benzimidazole derivative substrate. This solution, with the optional addition of a plasticizer, can be directly coated onto the substrate without any necessity for an intermediate layer. Furthermore, in this pH range, the enteric coating is optionally applicable in an aqueous solution, thereby obviating the need for organic solvents for dissolving the enteric coating material. The resultant formulation maintains the stability of the benzimidazole derivative during storage and at the same time protects the product during passage through the acidic environment of the stomach. The problem of interaction between the enteric coat and the alkaline core is thus completely eliminated as the enteric coat at this stage is no longer acidic.
Inventor(s): Lahav; Raffael (Qiriat Bialik, IL), Azoulay; Valerie (Pardes Hana, IL)
Assignee: Dexcel Ltd. (Or-Akiva, IL)
Application Number:11/785,300
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,023,391
Patent Claim Types:
see list of patent claims
Composition; Formulation; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,023,391: A Detailed Analysis

Introduction

Patent 9,023,391, like any other patent, is a complex document that outlines the invention, its claims, and the scope of protection it offers. To fully comprehend this patent, it is essential to delve into its various components and the broader patent landscape.

What is Patent 9,023,391?

Patent 9,023,391 is a utility patent granted by the United States Patent and Trademark Office (USPTO). To understand its specifics, one would typically refer to the patent's abstract, description, and claims.

Abstract and Description

The abstract provides a brief summary of the invention, while the description section offers a detailed explanation of the invention, including its background, summary, and detailed description. This section often includes drawings and diagrams to help illustrate the invention.

Claims

The claims section is the most critical part of a patent as it defines the scope of the invention and what is protected by the patent. Claims can be independent or dependent, with independent claims standing alone and dependent claims referring back to an independent claim.

Independent Claims

Independent claims define the broadest scope of the invention. They are self-contained and do not rely on other claims for their meaning.

Dependent Claims

Dependent claims narrow down the scope of the invention by adding specific limitations to an independent claim. These claims are often used to provide additional protection by covering various aspects of the invention.

Scope of Protection

The scope of protection for a patent is determined by its claims. Here are some key points to consider:

Claim Language

The language used in the claims is crucial. It must be clear and specific to avoid ambiguity and ensure that the scope of protection is well-defined. Recent studies have shown that metrics such as independent claim length and independent claim count can be used to measure patent scope and quality[3].

Patent Eligibility

Under the USPTO's guidance, particularly the 2024 update on AI and software-related emerging technologies, the eligibility of a patent claim is determined by whether it integrates a judicial exception into a practical application. This involves assessing whether the claim imposes meaningful limits on the exception, transforming it into patent-eligible subject matter[1].

Patent Landscape

Understanding the patent landscape is essential for innovators and patent practitioners. Here are some key aspects:

Prior Art Search

Conducting a thorough prior art search is crucial to ensure that the invention is novel and non-obvious. The USPTO provides various tools for this purpose, including the Patent Public Search tool, Global Dossier, and access to international patent databases[4].

Patent Classification

Patents are classified into various categories to help in searching and identifying related inventions. The classification system aids in determining the breadth of patent classes and the novelty of the invention.

International Considerations

Patents can be searched and compared across international databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO)[4].

Recent USPTO Guidance on AI Patents

The 2024 USPTO guidance update on AI patents is particularly relevant for understanding the current landscape.

AI-Assisted Inventions

The update clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies[1].

Practical Applications

The guidance emphasizes the importance of demonstrating how the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field. For example, Claim 2 in the guidance illustrates how specifying the use of separated audio components in a real-time speech recognition system enhances the accuracy of voice commands, making the claim patent-eligible[1].

Examples and Case Law

The USPTO has introduced new examples specifically tailored to AI technologies. These examples, such as Example 47 and Example 48, illustrate how claims involving AI can meet the eligibility criteria by demonstrating an improvement in computer technology or providing a practical application[1].

Impact on Innovators and Practitioners

The updated guidance provides more tools for evaluating the patentability of an invention and drafting claims that are more likely to avoid section 101 rejections. This is particularly important for innovators and practitioners working in the AI and software fields, as it helps ensure that their inventions are protected while adhering to the latest legal standards and interpretations.

Key Takeaways

  • Claim Language and Scope: The language used in claims is critical for defining the scope of protection.
  • Patent Eligibility: Claims must integrate judicial exceptions into practical applications to be patent-eligible.
  • AI-Assisted Inventions: The use of AI in invention development does not affect subject matter eligibility.
  • Practical Applications: Demonstrating real-world applications of the claimed method or system is crucial for patent eligibility.
  • Prior Art Search: Thorough searches are necessary to ensure novelty and non-obviousness.
  • International Considerations: Patents must be considered in the context of international databases and classifications.

FAQs

What is the significance of the 2024 USPTO guidance update on AI patents?

The update refines and clarifies the process for determining the patent eligibility of AI-related inventions, providing more tools for evaluating patentability and drafting claims that avoid common rejections.

How do AI-assisted inventions impact patent eligibility?

The method of invention development, including the use of AI, does not impact subject matter eligibility. The focus remains on the claimed invention itself, ensuring equal evaluation with other technologies.

What are the key factors in determining patent eligibility for AI-related claims?

Claims must integrate judicial exceptions into practical applications, demonstrating concrete technological improvements or solving specific problems in the relevant field.

How can innovators ensure their AI-related inventions meet patent eligibility criteria?

Innovators should focus on demonstrating real-world applications of their claimed methods or systems, ensuring that the abstract idea is transformed into a specific, practical application.

What resources are available for conducting prior art searches?

The USPTO provides tools such as the Patent Public Search tool, Global Dossier, and access to international patent databases to aid in prior art searches.

Cited Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. U.S. Patent and Trademark Office (USPTO) | USAGov
  3. Patent Claims and Patent Scope - SSRN
  4. Search for patents - USPTO

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,023,391

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Dexcel Pharma OMEPRAZOLE omeprazole TABLET, DELAYED RELEASE;ORAL 022032-001 Dec 4, 2007 OTC Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,023,391

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Israel130602Jun 22, 1999

International Family Members for US Patent 9,023,391

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 390119 ⤷  Subscribe
Australia 5423200 ⤷  Subscribe
Canada 2377605 ⤷  Subscribe
Germany 60038447 ⤷  Subscribe
European Patent Office 1187599 ⤷  Subscribe
Spain 2304349 ⤷  Subscribe
Israel 130602 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.